高清不卡日本v二区在线,天天综合网天天综合,激情丁香五月天婷婷水蜜桃视频,91精品免费久久久久久久久,手机看片久久久久久久久,日日夜夜嫩草,日本不卡 在线视频,欧美亚洲日韩,高潮歹无毛免费观看视频,天天综合网7799日日夜夜永,欧美日本国产日韩激情视频 ,久久久无码精品亚洲日韩蜜桃,日夜夜天天人人综合网,91蜜桃长长久久,国产精品精品一区在线发布,一级a毛片免费观看久久精品

Is On-Site Audit Required for Medical Device Registration in the United States?
Category：行業(yè)資訊 Date：2024-07-24 16:56:18 Author: Source:
Manufacturers should be prepared for potential inspections by maintaining a state of readiness, ensuring facilities comply with FDA regulations, and facilitating open communication with FDA inspectors. While on-site audits are not universally required for initial registration, understanding and fulfilling FDA's expectations for compliance can help expedite the approval process and ensure continued market access for medical devices in the United States.

For medical device registration in the United States, on-site audits, also known as inspections, are not always required as part of the initial registration process. The U.S. Food and Drug Administration (FDA) primarily relies on the submission of comprehensive documentation and data to assess compliance with regulatory requirements. This includes technical files, quality management system (QMS) documentation, clinical trial results (if applicable), and other relevant information.7(1).jpg

However, the FDA reserves the right to conduct inspections of manufacturing facilities and other establishments as part of its regulatory oversight. These inspections may occur either pre-approval (before granting market authorization) or post-approval to verify compliance with FDA regulations, including the Quality System Regulation (QSR) outlined in 21 CFR Part 820.

Factors influencing the need for on-site audits include:

  1. Device Classification: Higher-risk devices (Class II and III) are more likely to undergo inspections compared to lower-risk devices (Class I).

  2. Submission Type: Submissions requiring premarket approval (PMA) or significant clinical data may prompt FDA to conduct facility inspections to assess manufacturing practices and ensure data integrity.

  3. Quality System Compliance: Manufacturers must demonstrate adherence to QSR through documentation and may be subject to inspection to verify compliance with these standards.

  4. Post-Market Surveillance: FDA may conduct inspections post-market to monitor ongoing compliance, investigate complaints, or assess changes to the device or manufacturing processes.

Manufacturers should be prepared for potential inspections by maintaining a state of readiness, ensuring facilities comply with FDA regulations, and facilitating open communication with FDA inspectors. While on-site audits are not universally required for initial registration, understanding and fulfilling FDA's expectations for compliance can help expedite the approval process and ensure continued market access for medical devices in the United States.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn